Skip to main content

Peer Review reports

From: Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study

Original Submission
20 Oct 2016 Submitted Original manuscript
2 Dec 2016 Reviewed Reviewer Report - Tatjana Pekmezovic
28 Dec 2016 Reviewed Reviewer Report - Adam Handel
10 Feb 2017 Author responded Author comments - Meritxell Sabidó Espin
Resubmission - Version 2
10 Feb 2017 Submitted Manuscript version 2
Publishing
6 Mar 2017 Editorially accepted
23 Mar 2017 Article published 10.1186/s12883-017-0831-4

You can find further information about peer review here.

Back to article page